In last trading session, Avid Bioservices Inc (NASDAQ:CDMO) saw 1.38 million shares changing hands with its beta currently measuring 1.56. Company’s recent per share price level of $7.67 trading at $0.04 or 0.52% at ring of the bell on the day assigns it a market valuation of $486.89M. That closing price of CDMO’s stock is at a discount of -145.89% from its 52-week high price of $18.86 and is indicating a premium of 46.94% from its 52-week low price of $4.07. Taking a look at company’s average trading volume volume of 1.36 million if we extend that period to 3-months.

Avid Bioservices Inc (NASDAQ:CDMO) trade information

Upright in the green during last session for gaining 0.52%, in the last five days CDMO remained trading in the green while hitting it’s week-highest on Wednesday, 05/01/24 when the stock touched $7.67 price level, adding 2.29% to its value on the day. Avid Bioservices Inc’s shares saw a change of 18.00% in year-to-date performance and have moved 12.30% in past 5-day. Avid Bioservices Inc (NASDAQ:CDMO) showed a performance of 20.22% in past 30-days.

Avid Bioservices Inc (CDMO) estimates and forecasts

This year revenue growth is estimated to fall -6.80% from the last financial year’s standing.

5 industry analysts have given their estimates about the company’s current quarter revenue by setting an average figure of $42.14 million for the same. And 3 analysts are in estimates of company making revenue of $40.72 million in the next quarter that will end on Jul 2024. Company posted $39.8 million and -$ of sales in current and next quarters respectively a year earlier.

In 2024, company’s earnings growth rate is likely to be around -3275.00% while estimates for its earnings growth in next 5 years are of 15.00%.

CDMO Dividends

Avid Bioservices Inc is more likely to be releasing its next quarterly report in June and investors are confident in the company announcing better current-quarter dividends despite the fact that it has been facing issues arising out of mounting debt.